Annual Meeting

The Abstract Submission Portal for the 2026 Annual Meeting is now closed. If you need any assistance, please contact the ASNM at asnm@affinity-strategies.com.

Notifications Sent: Wednesday, April 1, 2026

35th Annual Meeting of the American Society of Neurophysiological Monitoring

TARGET AUDIENCE

Neurophysiologic Intraoperative Monitoring  Providers (CNIM/DABNM), Electroencephalographic Technologists (EEG), Evoked Potential (EP Technologists), Physicians, Anesthesiologists, Surgeons

GENERAL GUIDELINES FOR ALL SUBMISSION TYPES 

1. Abstracts must be submitted online through the abstract submission portal. No fax copies or email submissions will be accepted. By submitting an abstract, you agree to receive necessary email communications from the ASNM related to your submission and if accepted as a platform or physical poster, you agree to present your abstract at the ASNM 2026 meeting. These will be sent regardless of your other email preferences and may include, but not be limited to, status of your abstract, presenter information and reminders to complete unfinished submissions.
2. The abstract submitter retains “owner” rights until the submission deadline, then once accepted the presenter becomes the owner and receives all communications including the right to withdraw an abstract.
3. You will not be able to access the system after 11:59 pm Central Time on February 15, 2026. You can enter your abstract, save it, and return for edits or updates any time prior to the deadline.
4. Changes to abstract titles or abstract text will not be permitted after submission. Proofread your abstract to identify and correct any errors before submission.
5. Submission of an abstract constitutes a commitment by the author(s) to present their work if the abstract is accepted as a platform and physical poster.
6. By submitting an abstract, the authors grant permission to the ASNM to publish the accepted abstract and learning objectives in the online program. 
7. Promissory abstracts are discouraged; abstracts submitted to multiple program areas from the same author(s) or institutions on identical or similar topics will be withdrawn by the ASNM at its discretion.
8. Your presentation must be balanced and contain no commercial promotional content.
9. All submissions must be HIPAA-compliant. To preserve the anonymity of patients and research subjects, authors/presenters must remove all potentially identifying information—including patient likenesses, identification numbers, names, initials, etc.—from images, charts, graphs, tables, and text before being displayed at the Annual Meeting.
10. All abstracts submitted to the ASNM should have IRB/IACUC approval or a waiver or clearly explain why it is not applicable.
11. Notification of the status of submissions will be sent electronically to the abstract owner on or about April 1, 2026. 
12. The ASNM registration and housing is the responsibility of each individual presenter. Participants take part at their own expense and must be officially registered for the conference. Information on registration and hotel accommodations will be available at www.asnm.org.
13. If an abstract must be withdrawn after deadline, please email asnm@affinity-strategies.com. Include your name, confirmation number and abstract title.
14. Blind Peer Review Policy: In accordance with the ASNM abstract blind peer review policy, your submission title, abstract, or uploaded figures should not contain author names, institution names, general location, or any such information that may identify where the work originated.
15. Financial Support Notice: The ASNM strives to maintain the highest standards in development of its educational programming to ensure it remains free of commercial influence. To comply with the ACCME guidelines:  

• • A presenter is not to receive financial support in conjunction with their ASNM presentation(s) except from their employer. 
  • A person who is employed by a “commercial interest” (defined as any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients) cannot speak if the CME content relates to the business lines and products of its employer. 

The ASNM requires that the content of its accredited CME activities provide balance, independence, objectivity, and scientific rigor. Planning and development of the clinical content and format must be free of the influence or control of a commercial entity and must promote improvements or quality in healthcare and not a specific business interest of any commercial interest (e.g., no commercial bias). 

All accredited CME activities must be compliant with the ACCME content validation statements:

• All recommendations for patient care in accredited continuing education must be based on current science, evidence, and clinical reasoning, while giving a fair and balanced view of diagnostic and therapeutic options.
• All scientific research referred to, reported, or used in accredited education in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation.
• Although accredited continuing education is an appropriate place to discuss, debate, and explore new and evolving topics, these areas need to be clearly identified as such within the program and individual presentations. It is the responsibility of accredited providers to facilitate engagement with these topics without advocating for, or promoting, practices that are not, or not yet, adequately based on current science, evidence, and clinical reasoning.
• Organizations cannot be accredited if they advocate for unscientific approaches to diagnosis or therapy, or if their education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

DESCRIPTION OF ABSTRACT TYPES

Scientific Research 
Scientific abstracts describe completed hypothesis-driven research with a comprehensive report; a work-in-progress report of ongoing research of emerging ideas and techniques and containing initial yet defined results; or a brief pertinent report of a particular new aspect or understanding of neurophysiology. Some aspect must be original to reflect new progress. The abstract must include some aspect of surgical neurophysiology related research. Sample sizes should be greater than three. 

Case Studies/Series
Case studies/series should include information on the clinical relevance and importance of the case. The abstract should highlight the unique or novel contribution of the case. The abstract must be surgical neurophysiology related. When possible, outcome information should be reported. 

Literature Reviews
Reviews should be literature driven and a meta-analysis is acceptable if the conclusion is new.

Instructional Education
Instructional Education submissions should be designed to teach or review neurophysiologic signals, pathologic correlations, procedures, techniques, treatments, and interventions. The content may include other aspects related to teaching neurophysiology. Please note the Instructional Education category is not eligible for platform presentation. 

PRESENTATION FORMAT

Abstract presentations are accepted as live platform presentations, physical posters to be hung in the viewing hall, or e-posters viewable in the conference meeting app. The ASNM Research Committee will select the final format of abstract presentations. When initiating your submission, please indicate your format preference by choosing one of the three format types: Platform presentation/physical poster, physical poster only, or e-poster only. Abstracts cannot be changed after submission; no corrections will be allowed.

Platform Presentations: Presenters will receive a designated time slot to speak at the annual meeting. 

Physical Posters: Presenters will bring a physical poster to the meeting to hang in the poster hall and stand by their poster at the designated times.

E-Poster: E-Posters should consist of one PowerPoint slide using the 16:9 ratio resolution setting saved as a .PDF file, sans serif font, no video, maximum file size 10 MB. 

ABSTRACT CONTENTS

Each abstract submission should include the title of the presentation, authors and affiliations, date and location of the presentation, introduction, methods, results, discussion, and references.

SCIENTIFIC RIGOR

Accepted platforms will be expected to transparently report experimental design and analytical methods. Efforts should include blinding, statistics, sample sizes, and replication. Error bars should be defined. There should be no protected health information within the abstracts or presentations. 

AWARDS

Platform presentations and physical posters will be eligible for awards.  Any eligible abstracts will be automatically considered for awards by the Research Committee. If your abstract receives an award, you will be notified in April.

PREVIOUSLY PRESENTED/PUBLISHED POLICY

Abstract consideration for scientific presentations requires that all the criteria indicated below must be met. The ASNM reserves the right to accept or reject any abstract according to its usual and customary peer-review process.

1. The abstract must represent original work by the author.
2. Papers based on the abstract have not been published prior to the abstract submission deadline date.
3. The ASNM requires at the time of abstract submission that previously presented abstracts, in whole or in part, be labeled as such and the specific meeting be identified. It also requires that authors certify that no other organization has any rights to the material.

 For general questions or additional information, please contact the ASNM office: asnm@affinity-strategies.com